Mishra Archana, Maiti Rituparna, Mishra Biswa Ranjan, Jena Monalisa, Srinivasan Anand
Department of Pharmacology and Psychiatry, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, India.
J Clin Neurol. 2020 Jan;16(1):9-18. doi: 10.3988/jcn.2020.16.1.9.
The role of low-frequency repetitive transcranial stimulation (rTMS) in drug-resistant epilepsy (DRE) has been conflicting and inconclusive in previous clinical trials. This meta-analysis evaluated the efficacy of rTMS on seizure frequency and epileptiform discharges in DRE.
A standard meta-analysis protocol was registered in the International Prospective Register of Ongoing Systematic Reviews (PROSPERO: CRD42018088544). After performing a comprehensive literature search using specific keywords in MEDLINE, the Cochrane database, and the International Clinical Trial Registry Platform (ICTRP), reviewers assessed the eligibility and extracted data from seven relevant clinical trials. Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines were followed in the selection, analysis, and reporting of findings. A random-effects model was used to estimate the effect size as the mean difference in seizure frequency and interictal epileptiform discharges between the groups. Quality assessment was performed using a risk-of-bias assessment tool, and a meta-regression was used to identify the variables that probably influenced the effect size.
The random-effects model analysis revealed a pooled effect size of -5.96 (95% CI= -8.98 to -2.94), significantly favoring rTMS stimulation (=0.0001) over the control group with regard to seizure frequency. The overall effect size for interictal epileptiform discharges also significantly favored rTMS stimulation (<0.0001), with an overall effect size of -9.36 (95% CI=-13.24 to -5.47). In the meta-regression, the seizure frequency worsened by 2.00±0.98 (mean±SD, =0.042) for each week-long lengthening of the posttreatment follow-up period, suggesting that rTMS exerts only a short-term effect.
This meta-analysis shows that rTMS exerts a significant beneficial effect on DRE by reducing both the seizure frequency and interictal epileptiform discharges. However, the meta-regression revealed only an ephemeral effect of rTMS.
在先前的临床试验中,低频重复经颅磁刺激(rTMS)在药物难治性癫痫(DRE)中的作用一直存在争议且尚无定论。本荟萃分析评估了rTMS对DRE患者癫痫发作频率和癫痫样放电的疗效。
在国际前瞻性系统评价注册库(PROSPERO:CRD42018088544)中登记了一项标准的荟萃分析方案。使用特定关键词在MEDLINE、Cochrane数据库和国际临床试验注册平台(ICTRP)中进行全面文献检索后,评审人员评估了七项相关临床试验的入选资格并提取了数据。在研究的选择、分析和报告过程中遵循了系统评价和荟萃分析的首选报告项目(PRISMA)指南。采用随机效应模型估计效应量,即两组间癫痫发作频率和发作间期癫痫样放电的平均差异。使用偏倚风险评估工具进行质量评估,并采用荟萃回归分析来确定可能影响效应量的变量。
随机效应模型分析显示,在癫痫发作频率方面,合并效应量为-5.96(95%CI = -8.98至-2.94),rTMS刺激组显著优于对照组(P = 0.0001)。发作间期癫痫样放电的总体效应量也显著支持rTMS刺激(P < 0.0001),总体效应量为-9.36(95%CI = -13.24至-5.47)。在荟萃回归分析中,治疗后随访期每延长一周,癫痫发作频率恶化2.00±0.98(均值±标准差,P = 0.042),这表明rTMS仅产生短期效应。
本荟萃分析表明,rTMS通过降低癫痫发作频率和发作间期癫痫样放电对DRE具有显著的有益作用。然而,荟萃回归分析显示rTMS仅具有短暂效应。